344 related articles for article (PubMed ID: 34089497)
1. Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome.
Falcetta P; Benelli E; Molinaro A; Di Cosmo C; Bagattini B; Del Ghianda S; Salvetti G; Fiore E; Pucci E; Fruzzetti F; Tonacchera M
J Endocrinol Invest; 2021 Dec; 44(12):2725-2733. PubMed ID: 34089497
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome.
Cupisti S; Kajaia N; Dittrich R; Duezenli H; W Beckmann M; Mueller A
Eur J Endocrinol; 2008 May; 158(5):711-9. PubMed ID: 18426831
[TBL] [Abstract][Full Text] [Related]
4. Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
El-Eshmawy MM; Ibrahim A; Bahriz R; Shams-Eldin N; Mahsoub N
BMC Endocr Disord; 2022 Dec; 22(1):315. PubMed ID: 36514085
[TBL] [Abstract][Full Text] [Related]
5. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
6. Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.
Patlolla S; Vaikkakara S; Sachan A; Venkatanarasu A; Bachimanchi B; Bitla A; Settipalli S; Pathiputturu S; Sugali RN; Chiri S
Gynecol Endocrinol; 2018 Mar; 34(3):238-242. PubMed ID: 29068242
[TBL] [Abstract][Full Text] [Related]
7. Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome.
Fruzzetti F; Fidecicchi T; Benelli E; Baldari F; Tonacchera M
J Endocrinol Invest; 2024 Apr; 47(4):927-936. PubMed ID: 37907709
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome.
Nadir A; Temizkan S; Ozderya A; Temizkan O; Orbay E; Aydin K
Gynecol Endocrinol; 2019 Feb; 35(2):128-132. PubMed ID: 30324855
[TBL] [Abstract][Full Text] [Related]
9. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
[TBL] [Abstract][Full Text] [Related]
10. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
[TBL] [Abstract][Full Text] [Related]
11. Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome.
Lazúrová I; Lazúrová Z; Figurová J; Ujházi S; Dravecká I; Mašlanková J; Mareková M
Physiol Res; 2019 Jun; 68(3):457-465. PubMed ID: 30904012
[TBL] [Abstract][Full Text] [Related]
12. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
13. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.
Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J
J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649
[TBL] [Abstract][Full Text] [Related]
14. The value of the free androgen index depends on the phenotype of polycystic ovary syndrome - a single-centre experience.
Ożga K; Krzyczkowska-Sendrakowska M; Hubalewska-Dydejczyk A; Gilis-Januszewska A; Ratajczak M; Ratajczak M; Chaykivska Z; Jach R
Endokrynol Pol; 2019; 70(4):330-335. PubMed ID: 30938834
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
16. The association of the lipidomic profile with features of polycystic ovary syndrome.
Moran LJ; Mundra PA; Teede HJ; Meikle PJ
J Mol Endocrinol; 2017 Jul; 59(1):93-104. PubMed ID: 28500248
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Androgen Levels, Endocrine and Metabolic Indices, and Clinical Findings in Women with Polycystic Ovary Syndrome in Uygur and Han Ethnic Groups from Xinjiang Province in China.
Zhao H; Song X; Zhang L; Xu Y; Wang X
Med Sci Monit; 2018 Sep; 24():6774-6780. PubMed ID: 30252834
[TBL] [Abstract][Full Text] [Related]
18. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
19. The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome.
He H; Feng J; Zhang S; Wang Y; Li J; Gao J; Cong J; Gong Y; Wu X
Front Endocrinol (Lausanne); 2021; 12():773781. PubMed ID: 35069437
[TBL] [Abstract][Full Text] [Related]
20. Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Lin XF; Wu RR; Du J; Liao YC; Du Y; Ye Y; Wang Y; Zhang XB; Wu C; Chen A
Clin Exp Obstet Gynecol; 2015; 42(3):315-20. PubMed ID: 26152001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]